Previous Page  3 / 7 Next Page
Information
Show Menu
Previous Page 3 / 7 Next Page
Page Background

Volume 7, Issue 5 (Suppl)

J Community Med Health Educ

ISSN: 2161-0711 JCMHE, an open access journal

Public Health Congress 2017

November 13-14, 2017

Page 12

conference

series

.com

November 13-14, 2017 Osaka, Japan

3

rd

World Congress on

Public Health, Nutrition & Epidemiology

Evidence based public health to precision public health

P

recision medicine by the personalized medicine now became possible. We can use genetic testing for drug metabolizing

enzymes such as CYPs to estimate the adverse effect or efficiency of the drug for each patient. We also can check the genetic

change of a cancer to see how it acts for the particular patient. Also, recent findings suggest possible genetic background for

high risk for many diseases such as cancer, hypertension, dementia, autism or allergy. These high-risk markers are effective

for prevention of the disease, which is a new style of public health. This precision public health is the key for making the

personalized prevention care the next step. This is possible not only by the genome data, but also transcriptomics, wearable

sensors and other big data can have relation. Also, such genotype combination with the food habit also has strong relation with

the disease. Neonatal screening or recent maternal blood genetic testing is also very effective to early find the inherited disease.

Evidence based public health is the key word for us. It is very important to get patient database for evidence based public health

and precision public health. For this purpose, we need big data to make the evidence.

Biography

Hiroshi Mizushima has his expertise in medical informatics, computer science, public health informatics, molecular biology, etc. He has graduated from University of

Tokyo, Faculty of Pharmaceutical Science in 1983 and obtained his PhD in 1988 at University of Tokyo. He has established Cancer Information Service and Cancer

Information Network at National Cancer Center and became Professor of Medical Omics Informatics at Tokyo Medical and Dental University in 2009. He moved

to National Institute of Public Health (NIPH) in 2011 and became Director of Center for Public Health Informatics at NIPH in 2017. He is currently the President of

Japan IT-Healthcare Association and others.

hmizushi@niph.go.jp

Hiroshi Mizushima

National Institute of Public Health, Japan

Hiroshi Mizushima, J Community Med Health Educ 2017, 7:5 (Suppl)

DOI: 10.4172/2161-0711-C1-029